The Feinstein Institute for Medical Research, Manhasset, NY 11030, USAandCohen Children's Medical Center of NY, New Hyde Park, NY 11040, USA.
Expert Rev Hematol. 2012 Aug;5(4):373-5. doi: 10.1586/ehm.12.31.
Shwachman-Diamond syndrome (SDS) is an autosomal recessive disease caused by mutations in the SBDS gene in approximately 90% of cases. SDS is characterized by exocrine pancreatic insufficiency and bone marrow failure, which predisposes to the development of myelodysplastic syndrome and/or acute myeloid leukemia. In a new report, the French national cohort studied 102 SDS patients with a median follow-up of 11.6 years, focusing on the natural history of severe cytopenias. The authors concluded that SDS patients with a young age (<3 months) at first symptomatic presentation or cytopenia at diagnosis were at a high risk of subsequent severe hematological complications (either malignant or nonmalignant). Their findings raise the possibility that a clinical algorithm may predict the subsequent development of hematological complications in SDS.
Shwachman-Diamond 综合征(SDS)是一种常染色体隐性疾病,约 90%的病例由 SBDS 基因突变引起。SDS 的特征是外分泌胰腺功能不全和骨髓衰竭,这使其易于发展为骨髓增生异常综合征和/或急性髓系白血病。在一项新的报告中,法国国家队列研究了 102 名 SDS 患者,中位随访时间为 11.6 年,重点研究了严重血细胞减少症的自然史。作者得出结论,首次出现症状时年龄较小(<3 个月)或诊断时即出现血细胞减少的 SDS 患者,随后发生严重血液学并发症(恶性或非恶性)的风险较高。他们的研究结果提示,临床算法可能有助于预测 SDS 患者随后发生血液学并发症的情况。